New gel injection shows promise for eye disease

NCT ID NCT02931175

Completed Disease control Sponsor: Quan Dong Nguyen Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 14, 2026 · Updated 18 times

Summary

This study tested a gel form of ACTH, a natural hormone, to treat non-infectious uveitis (eye inflammation). 28 adults with active inflammation received one of two doses of the gel as a shot under the skin. The goal was to see if it is safe and can reduce eye inflammation. The study did not aim to cure the disease, but to control it.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UVEITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Metropolitan Eye Research and surgery Institute

Waltham, Massachusetts, 02451, United States
Retina Centers Professional Corporation - RCPC

Cleveland, Ohio, 44139, United States
Retina Consultants of Houston

Bellaire, Texas, 77401, United States
Retina Vitreous Associates, Medical Group

Los Angeles, California, 90017, United States
Stanford University

Palo Alto, California, 94303, United States
TExas Retina Associates

Dallas, Texas, 75231, United States
Texas Retina Assiciates

Dallas, Texas, 75231, United States

Conditions

Explore the condition pages connected to this study.

UVEITIS